Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,440 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01192048Recruiting
Study genetics in congenital heart disease
This study looks at how genes may contribute to congenital heart disease. It may help researchers better understand causes and risk in families like yours.
Columbus, OhioAges Any age - NCT01171872Enrolling by invitation
Study blood and tissue gene signals in bowel inflammation
This study looks at gene activity (what your body’s genes are “doing”) in people with bowel inflammation during endoscopy or bowel surgery. It may help researchers understand inflammatory bowel disease and improve future diagnosis or treatments.
Baltimore, MarylandAges 7 years+ - NCT01102556Recruiting
Pancreas disease registry for people at risk or with pancreatic cancer
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
New York, New YorkAges 18–85 - NCT00260585Recruiting
Esophageal risk and tissue registry study
This study collects information and, if you already need blood tests or procedures, may take extra small tissue samples (biopsies) to better understand esophageal-related conditions. It may help researchers learn about risk and future management for people with certain esophagus or reflux-related diagnoses.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT00006150Recruiting
Understanding Hyper-IgE Syndrome: Natural History and Genetics
This study follows people with or suspected Hyper-IgE syndrome (a rare immune disorder causing repeated infections and skin problems) to understand how the condition develops, how best to manage it, and which genes are involved. Researchers also welcome healthy relatives of patients to help identify genetic patterns.
Bethesda, MarylandAges 1 month–120 years - NCT00557726Recruiting
Evaluation and care for inflammatory or infectious illnesses
This trial helps doctors evaluate possible infection or inflammation and decide on the best management plan. You may be able to receive specialized care at the NIH if the study team thinks your situation fits.
Bethesda, MarylandAges 3–100 - NCT00246857Recruiting
Screening study for inherited immune system conditions
This study screens people who may have an inherited immune system condition (like problems with immune cell growth or death) and their blood relatives. The goal is to understand the condition better by collecting blood samples for testing.
Bethesda, MarylandAges 1 month–100 years - NCT00009243Recruiting
Understanding How Strokes Develop: A Research Study
This study follows people who have had or are at risk for stroke to understand what causes strokes and how they develop over time. By participating, you help researchers learn more about stroke prevention and treatment.
Washington D.C., District of ColumbiaAges 18–120 - NCT01200953Recruiting
Study care after contact with serious infectious germs
This study helps doctors manage people who may have been exposed to, infected with, or are recovering from dangerous infectious germs (including emerging outbreaks). It may help by setting safe evaluation and care steps after these high-risk exposures.
Bethesda, MarylandAges 3–99 - NCT00001159Recruiting
Thyroid disorder natural history study
This study observes people with various thyroid conditions, including overactive or underactive thyroid, to learn more about how these disorders develop and progress over time. It may help improve future diagnosis and treatment.
Bethesda, MarylandAges 6 months–98 years - NCT00001230Recruiting
Understanding How Your Body Responds to Filarial Infection
This study looks at how the body's immune system reacts to filarial infections—parasitic worms that affect millions worldwide. Researchers will observe your infection and response to treatment to better understand the disease and improve future care.
Bethesda, MarylandAges 3–100 - NCT00004847RecruitingPhase 1
Understanding and Diagnosing Pheochromocytoma and Paraganglioma
This study helps doctors better understand and diagnose pheochromocytoma and paraganglioma—rare tumors that release stress hormones and cause high blood pressure and other symptoms. Researchers will study your medical history, blood and urine tests, imaging scans, and genetic information to improve how these conditions are found and understood.
Bethesda, MarylandAges 3–120 - NCT00047996Enrolling by invitation
Blood Donation Study for Blood Vessel Research
This study collects blood and urine samples from adults to help researchers understand diseases affecting blood vessels. Your donation helps scientists develop better treatments.
Bethesda, MarylandAges 18–100 - NCT03206099Recruiting
Genetic testing study for NIH participants
This study uses genetic testing to help understand the causes of certain diseases, including lung conditions. By joining, you may help researchers find better ways to diagnose and treat these conditions.
Washington D.C., District of ColumbiaAges 1 day–100 years - NCT07221669RecruitingPhase 3
Pre-symptomatic salanersen study for babies with SMA
This trial tests if the drug salanersen can help movement and is safe when given to babies diagnosed with spinal muscular atrophy before they show symptoms. It's for very young infants with specific genetic types of SMA.
Chicago, IllinoisAges birth–1 month - NCT07893158RecruitingPhase 2
Nicotine tablet for easing cigarette cravings
This study tests a fast-dissolving nicotine tablet that melts in the mouth. The aim is to see how quickly it helps relieve the urge to smoke in adult daily smokers who smoke within 30 minutes of waking up.
Mississauga, OntarioAges 19–65 - NCT07097142RecruitingPhase 3
Shorter versus usual radiation for bladder cancer with chemotherapy
This study compares a shorter course of radiation therapy to the usual longer course, for people with bladder cancer that has grown into the muscle layer. You will also receive the standard chemotherapy. The goal is to see if the shorter radiation is just as effective with fewer side effects.
Fairbanks, AlaskaAges 18 years+ - NCT05419492RecruitingPhase 1/Phase 2
Gene therapy study for children with dravet syndrome
This study tests a new gene therapy called ETX101 in children with Dravet syndrome caused by a specific genetic change. The treatment aims to help reduce seizures. The study will check if it is safe and works well.
San Francisco, CaliforniaAges 6 months–17 years - NCT07024706RecruitingPhase 2
New treatment for relapsed CLL or SLL after a prior combination therapy
This study tests a new treatment for people with CLL or SLL that has come back after their first combination therapy. Researchers want to see if this new drug works safely and effectively for people in your situation.
Boston, MassachusettsAges 18–130 - NCT07890987Recruiting
Ultrasound-guided skin lift for facial firmness
This study tests a new non-surgical ultrasound procedure that uses imaging to guide a skin-tightening treatment for the face. It aims to improve facial firmness and appearance without cuts or needles.
Marbella, MalagaAges 35–80 - NCT06593392RecruitingPhase 2
Study of a new itch treatment for teens on dialysis
This study tests a new medicine called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is a common and bothersome symptom of kidney disease, and this treatment may help improve quality of life.
ChengduAges 12–18 - NCT07893093RecruitingPhase 1
Safety study of an injection for people with obesity or overweight
This study tests a new injection called ASC36 in people who are overweight or have obesity, to see if it is safe, how the body processes it, and what effects it has. It may help with weight loss, but the main goal is safety.
San Antonio, TexasAges 18–65 - NCT07893106RecruitingPhase 1
Study of oral ASC36 for weight management in adults
This study is testing an oral tablet (ASC36) to see if it is safe and how well it works for weight loss in adults who are overweight or have obesity. It is a first-in-human trial, so researchers are also studying how the body absorbs and processes the drug.
South Miami, FloridaAges 18–65 - NCT07532655RecruitingPhase 1
Study of SYH2082 Injection in healthy volunteers
This trial tests a new medicine called SYH2082, given as an injection, to see how safe it is and how the body handles it. It is for healthy adults and will help determine the right dose for future studies.
Nedlands, Western AustraliaAges 18–65
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,440 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.